| Patient | Vivekananda |
|---|---|
| Date of birth | 1991-01-12 |
| Identifiers | MRN HR-NI032-SYN; SSN (made up) 000-32-9014 |
| Document date | 2026-03-09 |
| Author | Anjali Thornbury-Mensah, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Preventive visit; three weeks on metformin. [S]
Swami Vivekananda, 35, comes for his preventive visit three weeks after diabetes was confirmed. He takes metformin extended-release 1000 mg with the evening meal; the loose stools of the first week have settled. His thirst has eased, he gets up to pass urine once a night instead of three times, and his fasting readings on the home meter are 138 to 162 mg/dL. He has seen the dietitian. His home blood pressure averaged 136/86 over seven days. He kept the fortnightly fast last week with fruit, milk and water, as planned, without symptoms. He still lies awake for about two hours before he falls asleep. [S]
| Element | Detail |
|---|---|
| Visit | Periodic preventive visit, age 35 |
| Active conditions | Type 2 diabetes, new; moderately increased albuminuria, to be confirmed; raised blood pressure; mixed hyperlipidemia; long-standing insomnia |
| Medicines | Metformin extended-release 1000 mg with the evening meal |
| Home readings | Fasting glucose 138 to 162 mg/dL; blood pressure average 136/86 |
Health risk assessment. Completed by the patient on paper before the visit and reviewed with him by Dr. Thornbury-Mensah. [S]
| Domain | Finding |
|---|---|
| Self-rated health | Fair, and improving |
| Psychosocial | Lives in community with his brother monks and disciples; purposeful work; his faith and practice |
| Tobacco | No tobacco use now |
| Alcohol and drugs | None, by his vows (AUDIT-C 0) |
| Physical activity | Walks by the river each morning and evening; rides when he can |
| Nutrition | Mostly vegetarian monastery meals with fish at some; fewer sweets since seeing the dietitian; fasts twice a month |
| Sleep | Two hours to fall asleep most nights; rises before dawn; five hours' sleep |
| Diabetes distress | Low; he regards the illness calmly but wants it understood |
| Safety | No firearms; no violence |
| Travel | Plans to spend the summer and autumn travelling in the mountains |
| Activities of daily living | Independent |
| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | Energy better; weight steady at 73 kg after the earlier loss |
| Eyes | Negative | Reading vision a little blurred when glucose was high, now clearer |
| Ears, nose, mouth, and throat | Negative | No mouth or gum problems |
| Respiratory | Negative | No cough or breathlessness |
| Cardiovascular | Negative | No chest pain, palpitations or ankle swelling |
| Gastrointestinal | Negative | Loose stools of the first week of metformin settled |
| Genitourinary | Positive | Gets up once a night to pass urine, down from three times |
| Musculoskeletal | Negative | No joint pain |
| Integumentary | Negative | No foot sores or skin infections |
| Neurological | Negative | No numbness or tingling in the feet |
| Psychiatric | Negative | Mood steady; PHQ-9 3, from sleep and tiredness; GAD-7 2 |
11 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metformin extended-release 500 mg tablets: two tablets (1000 mg) with the evening meal, starting with one for the first week | 1000 mg with the evening meal | Oral route | 2026-02-16 to 2026-03-23 | completed | S |
| Losartan 25 mg oral tablet, one tablet daily | One tablet daily | Oral route | 2026-03-09 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-09 | Body height | 172 | cm | S |
| 2026-03-09 | Body weight | 73.4 | kg | S |
| 2026-03-09 | Body mass index (BMI) [Ratio] | 24.8 | kg/m2 | S |
| 2026-03-09 | Systolic blood pressure | 134 | mm[Hg] | S |
| 2026-03-09 | Diastolic blood pressure | 84 | mm[Hg] | S |
| 2026-03-09 | Heart rate | 76 | /min | S |
| 2026-03-09 | Respiratory rate | 14 | /min | S |
| 2026-03-09 | Body temperature | 36.7 | Cel | S |
| 2026-03-09 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-09 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 3 | {score} | S | ||
| 2026-03-09 | Generalized anxiety disorder 7 item (GAD-7) total score [Reported.PHQ] | 2 | {score} | S | ||
| 2026-03-09 | Total score [AUDIT-C] | 0 | {score} | S |
Vital signs recorded on 2026-03-09; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| Constitutional | Robust and well; weight 73.4 kg, BMI 24.8; blood pressure 134/84, pulse 76 |
| Head, eyes, ears, nose, and throat | Teeth and gums healthy |
| Neck | No thyroid enlargement |
| Respiratory | Clear |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Integumentary | No acanthosis nigricans; feet intact |
| Psychiatric | Warm, forthright and engaged |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Thirst, frequent urination day and night, tiredness and about 4 kg weight loss over two months, with a random glucose of 246 mg/dL; told by physicians a year ago that he had diabetes, never confirmed with modern tests or treated except by diet. Diabetes to be confirmed and classified (type 2, type 1 or slowly progressive autoimmune diabetes) with A1c, fasting glucose, GAD antibodies and C-peptide | resolved | confirmed | R73.9 | S — Synthetic presenting problem anchored to his documented diabetes of the year before. Superseded by the diagnosis at the second visit. |
| Type 2 diabetes: A1c 9.4 percent and fasting glucose 172 mg/dL, with symptoms; GAD65 antibodies negative and fasting C-peptide preserved (2.6 ng/mL); no ketones. BMI 24.6, in the range where ADA screens Asian Americans. Classified as type 2, not type 1 or slowly progressive autoimmune diabetes | active | confirmed | E11.65 | S — Synthetic modern confirmation and classification linked to his documented diabetes. |
| Moderately increased albuminuria on a first sample (urine albumin-to-creatinine ratio 46 mg/g), eGFR normal; to be confirmed on two of three samples over three to six months | active | confirmed | R80.9 | S — Synthetic finding linked to his documented albuminuria; superseded when diabetic kidney disease was confirmed. |
| Raised blood pressure in clinic (138/86, average of two readings) without a diagnosis of hypertension; home readings to be taken | resolved | confirmed | R03.0 | S — Synthetic finding; not a claim about his real blood pressure. |
| Hypertension, stage 1: clinic 138/86, 136/86 and 134/84; home average 136/86 over seven days; with moderately increased albuminuria and diabetes | active | confirmed | I10 | S — Synthetic finding of the modern episode; not a claim about his real blood pressure, which was never recorded. |
| Long-standing difficulty falling asleep: by his own account he has never been able to fall asleep on getting into bed and lies awake for two hours or more most nights; worse lately with waking to pass urine; rises before dawn for meditation | active | confirmed | G47.00 | S — Synthetic modern problem linked to his documented lifelong difficulty falling asleep. |
| Mixed hyperlipidemia: LDL cholesterol 132 mg/dL, triglycerides 228, HDL 36 | active | confirmed | E78.2 | S — Synthetic cardiovascular risk factor. |
Personalized prevention plan. A written copy was given to the patient. [S]
| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 134/84 in clinic; home 136/86; treatment started |
| Depression screening | Completed today | PHQ-9 score 3; item 9 scored 0 |
| Anxiety screening | Completed today | GAD-7 score 2 |
| Unhealthy alcohol use screening | Completed today | AUDIT-C score 0 |
| Hepatitis B screening | Ordered | Born in a country where hepatitis B is common; drawn today |
| Latent tuberculosis infection screening | Ordered | Born in a country where tuberculosis is common; interferon-gamma release assay drawn today |
| HIV and hepatitis C screening | Ordered | Once-in-adulthood tests drawn today with his agreement |
| Diabetes and cholesterol | Up to date | A1c 9.4 percent and lipids three weeks ago; under treatment |
| Diabetic eye examination | Ordered | Retinal photographs booked for the next visit |
| Colorectal and prostate cancer screening | Not indicated | Not due at 35 |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap given; no adult record |
| Hepatitis B vaccine | Completed today | HepB-CpG dose 1 of 2 (diabetes, age 19 to 59) |
| Pneumococcal vaccine | Up to date | PCV20 three weeks ago (diabetes) |
| Influenza and COVID-19 vaccines | Up to date | Given three weeks ago |
| Zoster vaccine | Not indicated | From 50 |
Immunizations given today: Tdap vaccine (no record of a tetanus vaccine in adulthood); Hepatitis B vaccine (HepB-CpG), dose 1 of 2 [S]
Guideline basis: 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026 (2026); Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026); Adult Immunization Schedule by Age (2026); Adult Immunization Schedule by Medical Condition and Other Indication (2026)
Follow-up: Potassium and creatinine with the diabetes review in two weeks, with retinal photographs and the screening results. Hepatitis B dose 2 in a month or on his return. Next preventive visit in one year. Next scheduled visit 2026-03-23: five-week diabetes review before a long journey: glucose log, metformin dose, kidney function and potassium on losartan, repeat urine albumin, retinal photographs, statin, and a travel and fasting plan. [S]
Voluntary advance care planning discussion of about 20 minutes, with his consent. He named a health care agent, a brother monk of his order, recorded in the confidential part of the chart and not named here. He wants treatment for any illness he could recover from. If he were dying, he would want to be at the monastery, not in a hospital, with the rites of his tradition and with chanting, and without measures that would only prolong dying. He asked that the clinic respect his monastic practices and his fasting at the end of life as at other times. To be revisited at any change in his health and at least yearly. [S]